Senior Fellow Richard Epstein discusses his recent Defining Ideas article "Obamacare's Slow Death?" on the John Batchelor Show.

The development of pharmaceuticals is among the riskiest of businesses. It now takes 10-15 years for a pharmaceutical company to get a new drug approved, and on average the cost exceeds $2.5 billion.

England’s National Health Service is struggling to handle the ever-growing demand for emergency care this winter, and more hospitals have had to declare “major incident” emergency plans.

The new Republican majority in Congress is expected to repeal the tax on medical devices, and a vote could come during January. A provision in the Patient Protection and Affordable Care Act (ACA) enacted a 2.3 percent excise tax on the manufacture and importation of medical equipment and supplies.